标题
Structure, function and inhibition of the phosphoinositide 3-kinase p110α enzyme
作者
关键词
-
出版物
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 42, Issue 1, Pages 120-124
出版商
Portland Press Ltd.
发表日期
2014-01-23
DOI
10.1042/bst20130255
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of PI3Kβ-Selective Inhibition Revealed by Reciprocal Mutagenesis
- (2013) Zhaohua Zheng et al. ACS Chemical Biology
- Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
- (2013) Pascal Furet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Gain of Interaction with IRS1 by p110α-Helical Domain Mutants Is Crucial for Their Oncogenic Functions
- (2013) Yujun Hao et al. CANCER CELL
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
- (2013) Ralph Fritsch et al. CELL
- Extended treatment with selective phosphatidylinositol 3-kinase and mTOR inhibitors has effects on metabolism, growth, behaviour and bone strength
- (2013) Greg C. Smith et al. FEBS Journal
- Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
- (2013) Adriana Soler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα
- (2013) Mariana Nacht et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Characterization of a Tumor-Associated Activating Mutation of the p110β PI 3-Kinase
- (2013) Hashem A. Dbouk et al. PLoS One
- Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity
- (2013) Christina M. Buchanan et al. PLoS One
- mTORC1 Inhibition Is Required for Sensitivity to PI3K p110 Inhibitors in PIK3CA-Mutant Breast Cancer
- (2013) M. Elkabets et al. Science Translational Medicine
- Protein Kinase Activity of Phosphoinositide 3-Kinase Regulates Cytokine-Dependent Cell Survival
- (2013) Daniel Thomas et al. PLOS BIOLOGY
- Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors usingin vitromutagenesis of non-conserved amino acids and kinetic analysis
- (2012) Zhaohua Zheng et al. BIOCHEMICAL JOURNAL
- Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
- (2012) Ian Bruce et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
- (2012) F. Janku et al. CANCER RESEARCH
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110 (PIK3CA)
- (2012) J. E. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G Protein-Coupled Receptor-Mediated Activation of p110 by G Is Required for Cellular Transformation and Invasiveness
- (2012) H. A. Dbouk et al. Science Signaling
- PTEN in cancer, metabolism, and aging
- (2012) Ana Ortega-Molina et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types
- (2011) Stephen Jamieson et al. BIOCHEMICAL JOURNAL
- Effects of acutely inhibiting PI3K isoforms and mTOR on regulation of glucose metabolismin vivo
- (2011) Greg C. Smith et al. BIOCHEMICAL JOURNAL
- Novel pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR
- (2011) Jackie D. Kendall et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
- (2011) J. Hoellenriegel et al. BLOOD
- Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
- (2011) S. J. Shuttleworth et al. CURRENT MEDICINAL CHEMISTRY
- SHIP2 multiple functions: A balance between a negative control of PtdIns(3,4,5)P3level, a positive control of PtdIns(3,4)P2production, and intrinsic docking properties
- (2011) Christophe Erneux et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
- (2011) Xuxiao Zhang et al. MOLECULAR CELL
- Isoform-Selective Inhibition of Phosphoinositide 3-Kinase: Identification of a New Region of Nonconserved Amino Acids Critical for p110 Inhibition
- (2011) Z. Zheng et al. MOLECULAR PHARMACOLOGY
- Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases
- (2011) W-C Hon et al. ONCOGENE
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases
- (2010) Dima A. Sabbah et al. Journal of Chemical Information and Modeling
- The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
- (2010) Alex Berndt et al. Nature Chemical Biology
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
- (2010) C. G. Fedele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-derived mutations in the regulatory subunit p85 of phosphoinositide 3-kinase function through the catalytic subunit p110
- (2010) M. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional differences between two classes of oncogenic mutation in the PIK3CA gene
- (2009) Claire Chaussade et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Class I Phospho-inositide-3-kinases (PI3Ks) Isoform-Specific Inhibition Study by the Combination of Docking and Molecular Dynamics Simulation
- (2009) Ming Han et al. Journal of Chemical Information and Modeling
- A frequent kinase domain mutation that changes the interaction between PI3K and the membrane
- (2009) D. Mandelker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase
- (2008) Jeffrey D. Carson et al. BIOCHEMICAL JOURNAL
- Phosphoinositide-3-kinases (PI3Ks): Combined Comparative Modeling and 3D-QSAR To Rationalize the Inhibition of p110α
- (2008) Raphaël Frédérick et al. Journal of Chemical Information and Modeling
- Helical domain and kinase domain mutations in p110 of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
- (2008) L. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search